A study assessing a new asthma inhaler revealed that it has problems. This investigation was conducted subsequent to the decision of PHARMAC in 2005 to stop the funding for Ventolin inhalers in favour of Salamol.
In the study, 36 asthmatics using the Salamol inhaler were observed. Only 15 of them were able to stick to the study. The rest withdrew either due to the ineffectiveness of the drug or due to the taste. Asthma stability had deteriorated in 93% of the cases.
According to the report, several factors like psychological reasons, physical difference between inhalers and the ineffectiveness of the drug could have influenced the result.